Frequency and outcome of patients with nonthyroidal illness syndrome in a medical intensive care unit

Metabolism: Clinical and Experimental

Volumn 56, Issue 2, 2007, Pages 239-244

  Plikat, Katharina ^a   Langgartner, Julia ^a   Buettner, Roland ^a   Bollheimer, L Cornelius ^a   Woenckhaus, Ulrike ^a   Schölmerich, Jürgen ^a   Wrede, Christian E ^a  

^a UNIVERSITY HOSPITAL REGENSBURG   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

LIOTHYRONINE; THYROID HORMONE; THYROTROPIN; THYROXINE;

ADULT; APACHE; ARTICLE; ARTIFICIAL VENTILATION; CONTROLLED STUDY; EUTHYROID SICK SYNDROME; EVALUATION; FEMALE; FREE LIOTHYRONINE INDEX; FREE THYROXINE INDEX; HORMONE BLOOD LEVEL; HOSPITAL ADMISSION; HUMAN; INTENSIVE CARE UNIT; LENGTH OF STAY; MAJOR CLINICAL STUDY; MALE; MORTALITY; MULTIVARIATE LOGISTIC REGRESSION ANALYSIS; PREVALENCE; PRIORITY JOURNAL; PROPORTIONAL HAZARDS MODEL; RETROSPECTIVE STUDY; RISK FACTOR; SURVIVAL; THYROTROPIN BLOOD LEVEL; TREATMENT OUTCOME;

APACHE; EUTHYROID SICK SYNDROMES; FEMALE; HUMANS; INTENSIVE CARE; INTENSIVE CARE UNITS; MALE; MIDDLE AGED; REGRESSION ANALYSIS; SYNDROME; THYROID HORMONES; THYROTROPIN; THYROXINE; TRIIODOTHYRONINE;

EID: 33846061171     PISSN: 00260495     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.metabol.2006.09.020     Document Type: Article

References (38)

1. Bermudez F., Surks M.I., and Oppenheimer J.H. High incidence of decreased serum triiodothyronine concentration in patients with nonthyroidal disease. J Clin Endocrinol Metab 41 (1975) 27-40
2. McIver B., and Gorman C.A. Euthyroid sick syndrome: an overview. Thyroid 7 (1997) 125-132
3. Chow C.C., Mak T.W., Chan C.H., and Cockram C.S. Euthyroid sick syndrome in pulmonary tuberculosis before and after treatment. Ann Clin Biochem 32 Pt. 4 (1995) 385-391
4. Phillips R.H., Valente W.A., Caplan E.S., Connor T.B., and Wiswell J.G. Circulating thyroid hormone changes in acute trauma: prognostic implications for clinical outcome. J Trauma 24 (1984) 116-119
5. Eber B., Schumacher M., Langsteger W., Zweiker R., Fruhwald F.M., Pokan R., et al. Changes in thyroid hormone parameters after acute myocardial infarction. Cardiology 86 (1995) 152-156
6. Aun F., Medeiros-Neto G.A., Younes R.N., Birolini D., and de Oliveira M.R. The effect of major trauma on the pathways of thyroid hormone metabolism. J Trauma 23 (1983) 1048-1051
7. Reinhardt W., Mocker V., Jockenhövel F., Olbricht T., Reinwein D., Mann K., et al. Influence of coronary artery bypass surgery on thyroid hormone parameters. Horm Res 47 (1997) 1-8
8. Hennemann G., Docter R., and Krenning E.P. Causes and effects of the low T3 syndrome during caloric deprivation and non-thyroidal illness: an overview. Acta Med Austriaca 15 Suppl 1 (1988) 42-45
9. Peeters R.P., Wouters P.J., Kaptein E., van Toor H., Visser T.J., and Van den Berghe G. Reduced activation and increased inactivation of thyroid hormone in tissues of critically ill patients. J Clin Endocrinol Metab 88 (2003) 3202-3211
10. Köhrle J. Local activation and inactivation of thyroid hormones: the deiodinase family. Mol Cell Endocrinol 151 (1999) 103-119
11. Peeters R.P., Wouters P.J., van Toor H., Kaptein E., Visser T.J., and Van den Berghe G. Serum 3,3′,5′-triiodothyronine (rT3) and 3,5,3′-triiodothyronine/rT3 are prognostic markers in critically ill patients and are associated with postmortem tissue deiodinase activities. J Clin Endocrinol Metab 90 (2005) 4559-4565
12. Fliers E., Guldenaar S.E., Wiersinga W.M., and Swaab D.F. Decreased hypothalamic thyrotropin-releasing hormone gene expression in patients with nonthyroidal illness. J Clin Endocrinol Metab 82 (1997) 4032-4036
13. Docter R., Krenning E.P., de Jong M., and Hennemann G. The sick euthyroid syndrome: changes in thyroid hormone serum parameters and hormone metabolism. Clin Endocrinol (Oxf) 39 (1993) 499-518
14. Van den Berghe G., de Zegher F., Baxter R.C., Veldhuis J.D., Wouters P., Schetz M., et al. Neuroendocrinology of prolonged critical illness: effects of exogenous thyrotropin-releasing hormone and its combination with growth hormone secretagogues. J Clin Endocrinol Metab 83 (1998) 309-319
15. Van den Berghe G. Novel insights into the neuroendocrinology of critical illness. Eur J Endocrinol 143 (2000) 1-13
16. Annane D., Sebille V., Charpentier C., Bollaert P.E., Francois B., Korach J.M., et al. Effect of treatment with low doses of hydrocortisone and fludrocortisone on mortality in patients with septic shock. JAMA 288 (2002) 862-871
17. De Groot L.J. Dangerous dogmas in medicine: the nonthyroidal illness syndrome. J Clin Endocrinol Metab 84 (1999) 151-164
18. Leon-Sanz M., Lorente J.A., Larrodera L., Ros P., Alvarez J., Esteban A.E., et al. Pituitary-thyroid function in patients with septic shock and its relation with outcome. Eur J Med Res 2 (1997) 477-482
19. Silberman H., Eisenberg D., Ryan J., Shofler R., Niland J., Kaptein E., et al. The relation of thyroid indices in the critically ill patient to prognosis and nutritional factors. Surg Gynecol Obstet 166 (1988) 223-228
20. Slag M.F., Morley J.E., Elson M.K., Crowson T.W., Nuttall F.Q., and Shafer R.B. Hypothyroxinemia in critically ill patients as a predictor of high mortality. JAMA 245 (1981) 43-45
21. Knaus W.A., Draper E.A., Wagner D.P., and Zimmerman J.E. APACHE II: a severity of disease classification system. Crit Care Med 13 (1985) 818-829
22. Baue A.E., Gunther B., Hartl W., Ackenheil M., and Heberer G. Altered hormonal activity in severely ill patients after injury or sepsis. Arch Surg 119 (1984) 1125-1132
23. Custro N., Scafidi V., Costanzo G., and Notarbartolo A. Prospective study on thyroid function anomalies in severely ill patients. Ann Ital Med Int 7 (1992) 13-18
24. Kaplan M.M., Larsen P.R., Crantz F.R., Dzau V.J., Rossing T.H., and Haddow J.E. Prevalence of abnormal thyroid function test results in patients with acute medical illnesses. Am J Med 72 (1982) 9-16
25. Maldonado L.S., Murata G.H., Hershman J.M., and Braunstein G.D. Do thyroid function tests independently predict survival in the critically ill?. Thyroid 2 (1992) 119-123
26. Scoscia E., Baglioni S., Eslami A., Iervasi G., Monti S., and Todisco T. Low triiodothyronine (T3) state: a predictor of outcome in respiratory failure? Results of a clinical pilot study. Eur J Endocrinol 151 (2004) 557-560
27. Van den Berghe G., Baxter R.C., Weekers F., Wouters P., Bowers C.Y., Iranmanesh A., et al. The combined administration of GH-releasing peptide-2 (GHRP-2), TRH and GnRH to men with prolonged critical illness evokes superior endocrine and metabolic effects compared to treatment with GHRP-2 alone. Clin Endocrinol (Oxf) 56 (2002) 655-669
28. Loh K.C., and Eng P.C. Prevalence and prognostic relevance of sick euthyroid syndrome in a medical intensive care unit. Ann Acad Med Singapore 24 (1995) 802-806
29. Kaptein E.M., Robinson W.J., Grieb D.A., and Nicoloff J.T. Peripheral serum thyroxine, triiodothyronine and reverse triiodothyronine kinetics in the low thyroxine state of acute nonthyroidal illnesses. A noncompartmental analysis. J Clin Invest 69 (1982) 526-535
30. Brent G.A., and Hershman J.M. Thyroxine therapy in patients with severe nonthyroidal illnesses and low serum thyroxine concentration. J Clin Endocrinol Metab 63 (1986) 1-8
31. Becker R.A., Vaughan G.M., Ziegler M.G., Seraile L.G., Goldfarb I.W., Mansour E.H., et al. Hypermetabolic low triiodothyronine syndrome of burn injury. Crit Care Med 10 (1982) 870-875
32. Bennett-Guerrero E., Jimenez J.L., White W.D., D'Amico E.B., Baldwin B.I., and Schwinn D.A. Cardiovascular effects of intravenous triiodothyronine in patients undergoing coronary artery bypass graft surgery. A randomized, double-blind, placebo-controlled trial. Duke T3 study group. JAMA 275 (1996) 687-692
33. Klemperer J.D., Klein I., Gomez M., Helm R.E., Ojamaa K., Thomas S.J., et al. Thyroid hormone treatment after coronary-artery bypass surgery. N Engl J Med 333 (1995) 1522-1527
34. Weekers F., Michalaki M., Coopmans W., Van Herck E., Veldhuis J.D., Darras V.M., et al. Endocrine and metabolic effects of growth hormone (GH) compared with GH-releasing peptide, thyrotropin-releasing hormone, and insulin infusion in a rabbit model of prolonged critical illness. Endocrinology 145 (2004) 205-213
35. Van den Berghe G. Endocrine evaluation of patients with critical illness. Endocrinol Metab Clin North Am 32 (2003) 385-410
36. Sapin R., Schlienger J.L., Gasser F., Noel E., Lioure B., Grunenberger F., et al. Intermethod discordant free thyroxine measurements in bone marrow-transplanted patients. Clin Chem 46 (2000) 418-422
37. Laboratory support for the diagnosis and monitoring of thyroid disease. Published guidelines of the National Academy of Clinical Biochemistry (2003). http://www.aacc.org/AACC/members/nacb/LMPG/OnlineGuide/PublishedGuidedlines/ThyroidDisease/
38. Surks M.I., Hupart K.H., Pan C., and Shapiro L.E. Normal free thyroxine in critical nonthyroidal illnesses measured by ultrafiltration of undiluted serum and equilibrium dialysis. J Clin Endocrinol Metab 67 (1988) 1031-1039